FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group

Transplant Proc. 1997 Feb-Mar;29(1-2):304-5. doi: 10.1016/s0041-1345(96)00270-9.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase III
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antilymphocyte Serum / therapeutic use
  • Child
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use*
  • Diabetes Mellitus / epidemiology
  • Diabetes Mellitus / etiology
  • Drug Therapy, Combination
  • Female
  • Graft Rejection / epidemiology
  • Graft Rejection / prevention & control
  • Graft Survival*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / physiology
  • Male
  • Middle Aged
  • Muromonab-CD3 / therapeutic use
  • Neoplasms / epidemiology
  • Postoperative Complications / epidemiology
  • Tacrolimus / adverse effects
  • Tacrolimus / therapeutic use*
  • United States

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Cyclosporine
  • Tacrolimus